Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study.

Stolwijk C, Essers I, van den Bosch F, Dougados M, Etcheto A, van der Heijde D, Landewé R, Molto A, van Tubergen A, Boonen A.

Rheumatology (Oxford). 2019 Oct 26. pii: kez482. doi: 10.1093/rheumatology/kez482. [Epub ahead of print]

PMID:
31665462
2.

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis.

Kiltz U, Landewé RBM, van der Heijde D, Rudwaleit M, Weisman MH, Akkoc N, Boonen A, Brandt J, Carron P, Dougados M, Gossec L, Jongkees M, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compán V, Niederman K, Sampaio-Barros PD, Slobodin G, Van den Bosch FE, van Tubergen A, van Weely S, Wiek D, Braun J.

Ann Rheum Dis. 2019 Oct 11. pii: annrheumdis-2019-216034. doi: 10.1136/annrheumdis-2019-216034. [Epub ahead of print]

3.

Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts.

Boel A, Molto A, van der Heijde D, Ciurea A, Dougados M, Gensler LS, Santos MJ, De Miguel E, Poddubnyy D, Rudwaleit M, van Tubergen A, van Gaalen FA, Ramiro S.

Ann Rheum Dis. 2019 Nov;78(11):1545-1549. doi: 10.1136/annrheumdis-2019-215707. Epub 2019 Jul 30.

PMID:
31362994
4.

2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis.

Bech B, Primdahl J, van Tubergen A, Voshaar M, Zangi HA, Barbosa L, Boström C, Boteva B, Carubbi F, Fayet F, Ferreira RJO, Hoeper K, Kocher A, Kukkurainen ML, Lion V, Minnock P, Moretti A, Ndosi M, Pavic Nikolic M, Schirmer M, Smucrova H, de la Torre-Aboki J, Waite-Jones J, van Eijk-Hustings Y.

Ann Rheum Dis. 2019 Jul 12. pii: annrheumdis-2019-215458. doi: 10.1136/annrheumdis-2019-215458. [Epub ahead of print]

PMID:
31300458
5.

Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net).

Webers C, Beckers E, Boonen A, van Eijk-Hustings Y, Vonkeman H, van de Laar M, van Tubergen A.

RMD Open. 2019 Apr 11;5(1):e000860. doi: 10.1136/rmdopen-2018-000860. eCollection 2019.

6.

Prospective Follow-Up of Cortical Interruptions, Bone Density, and Micro-structure Detected on HR-pQCT: A Study in Patients with Rheumatoid Arthritis and Healthy Subjects.

Peters M, van den Bergh JP, Geusens P, Scharmga A, Loeffen D, Weijers R, van Rietbergen B, van Tubergen A.

Calcif Tissue Int. 2019 Jun;104(6):571-581. doi: 10.1007/s00223-019-00523-2. Epub 2019 Feb 1.

PMID:
30707271
7.

Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.

Webers C, Ramiro S, Landewé R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A, Boonen A.

RMD Open. 2018 Nov 27;4(2):e000766. doi: 10.1136/rmdopen-2018-000766. eCollection 2018.

8.

Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study.

Gerlag DM, Safy M, Maijer KI, Tang MW, Tas SW, Starmans-Kool MJF, van Tubergen A, Janssen M, de Hair M, Hansson M, de Vries N, Zwinderman AH, Tak PP.

Ann Rheum Dis. 2019 Feb;78(2):179-185. doi: 10.1136/annrheumdis-2017-212763. Epub 2018 Dec 1.

9.

Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life.

Imkamp M, Lima Passos V, Boonen A, Arends S, Dougados M, Landewé R, Ramiro S, Van den Bosch F, van der Heijde D, Wink FR, Spoorenberg A, van Tubergen A.

RMD Open. 2018 Nov 14;4(2):e000755. doi: 10.1136/rmdopen-2018-000755. eCollection 2018.

10.

Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease.

de Jong MJ, Roosen D, Degens JHRJ, van den Heuvel TRA, Romberg-Camps M, Hameeteman W, Bodelier AGL, Romanko I, Lukas M, Winkens B, Markus T, Masclee AAM, van Tubergen A, Jonkers DMAE, Pierik MJ.

J Crohns Colitis. 2019 Apr 26;13(5):555-563. doi: 10.1093/ecco-jcc/jjy196.

PMID:
30476099
11.

Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe.

Gottlieb A, Gratacos J, Dikranian A, van Tubergen A, Fallon L, Emir B, Aikman L, Smith T, Chen L.

Rheumatol Int. 2019 Jan;39(1):121-130. doi: 10.1007/s00296-018-4195-x. Epub 2018 Nov 13.

12.

Development of a scoring method to visually score cortical interruptions on high-resolution peripheral quantitative computed tomography in rheumatoid arthritis and healthy controls.

Scharmga A, Peters M, van den Bergh JP, Geusens P, Loeffen D, van Rietbergen B, Schoonbrood T, Vosse D, Weijers R, van Tubergen A.

PLoS One. 2018 Jul 9;13(7):e0200331. doi: 10.1371/journal.pone.0200331. eCollection 2018.

13.

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis.

Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S, Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J.

Ann Rheum Dis. 2018 Sep;77(9):1311-1317. doi: 10.1136/annrheumdis-2017-212076. Epub 2018 Jun 1.

14.

Are globals for health, well-being and quality of life interchangeable? A mixed methods study in ankylosing spondylitis patients and controls.

van Tubergen A, Gulpen A, Landewé R, Boonen A.

Rheumatology (Oxford). 2018 Sep 1;57(9):1555-1562. doi: 10.1093/rheumatology/key129.

PMID:
29788458
15.

Is radiographic progression in radiographic axial spondyloarthritis related to matrix metalloproteinase degradation of extracellular matrix?

Siebuhr AS, van der Heijde D, Bay-Jensen AC, Karsdal MA, Landewé R, van Tubergen A, Ramiro S.

RMD Open. 2018 May 14;4(1):e000648. doi: 10.1136/rmdopen-2018-000648. eCollection 2018.

16.

An automated algorithm for the detection of cortical interruptions and its underlying loss of trabecular bone; a reproducibility study.

Peters M, de Jong J, Scharmga A, van Tubergen A, Geusens P, Loeffen D, Weijers R, Boyd SK, Barnabe C, Stok KS, van Rietbergen B, van den Bergh J.

BMC Med Imaging. 2018 May 15;18(1):13. doi: 10.1186/s12880-018-0255-7.

17.

Assessment of Cortical Interruptions in the Finger Joints of Patients With Rheumatoid Arthritis Using HR-pQCT, Radiography, and MRI.

Peters M, van Tubergen A, Scharmga A, Driessen A, van Rietbergen B, Loeffen D, Weijers R, Geusens P, van den Bergh J.

J Bone Miner Res. 2018 Sep;33(9):1676-1685. doi: 10.1002/jbmr.3466. Epub 2018 Jun 7.

18.

Structural damage and inflammation on radiographs or magnetic resonance imaging are associated with cortical interruptions on high-resolution peripheral quantitative computed tomography: a study in finger joints of patients with rheumatoid arthritis and healthy subjects.

Scharmga A, Geusens P, Peters M, van den Bergh JP, Loeffen D, Schoonbrood T, van Rietbergen B, Vosse D, Weijers R, van Tubergen A.

Scand J Rheumatol. 2018 Nov;47(6):431-439. doi: 10.1080/03009742.2018.1424234. Epub 2018 Feb 20.

PMID:
29458275
19.

Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study.

Mariette X, Förger F, Abraham B, Flynn AD, Moltó A, Flipo RM, van Tubergen A, Shaughnessy L, Simpson J, Teil M, Helmer E, Wang M, Chakravarty EF.

Ann Rheum Dis. 2018 Feb;77(2):228-233. doi: 10.1136/annrheumdis-2017-212196. Epub 2017 Oct 13.

20.

The Prevalence of Latent Tuberculosis and Hepatitis B After Systematic Screening of Patients Prescribed Biological Therapy in a Low-endemic Area.

de Jong MJ, Roosen D, van Tubergen A.

J Crohns Colitis. 2018 Jan 5;12(1):124-125. doi: 10.1093/ecco-jcc/jjx108. No abstract available.

PMID:
28981641
21.

Vascular channels in metacarpophalangeal joints: a comparative histologic and high-resolution imaging study.

Scharmga A, Keller KK, Peters M, van Tubergen A, van den Bergh JP, van Rietbergen B, Weijers R, Loeffen D, Hauge EM, Geusens P.

Sci Rep. 2017 Aug 21;7(1):8966. doi: 10.1038/s41598-017-09363-2.

22.

Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study.

Clowse ME, Förger F, Hwang C, Thorp J, Dolhain RJ, van Tubergen A, Shaughnessy L, Simpson J, Teil M, Toublanc N, Wang M, Hale TW.

Ann Rheum Dis. 2017 Nov;76(11):1890-1896. doi: 10.1136/annrheumdis-2017-211384. Epub 2017 Aug 16.

23.

Exploring conditions for redistribution of anti-tumor necrosis factors to reduce spillage: A study on the quality of anti-tumor necrosis factor home storage.

de Jong MJ, Pierik MJ, Peters A, Roemers M, Hilhorst V, van Tubergen A.

J Gastroenterol Hepatol. 2018 Feb;33(2):426-430. doi: 10.1111/jgh.13920.

PMID:
28800384
24.

Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial.

de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, Becx MC, Maljaars JP, Cilissen M, van Bodegraven AA, Mahmmod N, Markus T, Hameeteman WM, Dijkstra G, Masclee AA, Boonen A, Winkens B, van Tubergen A, Jonkers DM, Pierik MJ.

Lancet. 2017 Sep 2;390(10098):959-968. doi: 10.1016/S0140-6736(17)31327-2. Epub 2017 Jul 14.

PMID:
28716313
25.

Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness-to-Pay Approach.

Webers C, Essers I, van Tubergen A, Braun J, Heldmann F, Baraliakos X, Boonen A.

Arthritis Care Res (Hoboken). 2018 Apr;70(4):608-616. doi: 10.1002/acr.23299. Epub 2018 Feb 18.

26.

An automated algorithm for the detection of cortical interruptions on high resolution peripheral quantitative computed tomography images of finger joints.

Peters M, Scharmga A, de Jong J, van Tubergen A, Geusens P, Arts JJ, Loeffen D, Weijers R, van Rietbergen B, van den Bergh J.

PLoS One. 2017 Apr 20;12(4):e0175829. doi: 10.1371/journal.pone.0175829. eCollection 2017. Erratum in: PLoS One. 2017 Jun 2;12 (6):e0179138.

27.

The Reliability of a Semi-automated Algorithm for Detection of Cortical Interruptions in Finger Joints on High Resolution CT Compared to MicroCT.

Peters M, Scharmga A, van Tubergen A, Arts J, Loeffen D, Weijers R, van Rietbergen B, Geusens P, van den Bergh JP.

Calcif Tissue Int. 2017 Aug;101(2):132-140. doi: 10.1007/s00223-017-0264-5. Epub 2017 Mar 28.

28.

GPs' patterns of clinical assessment when faced with a patient suspected for spondyloarthritis: a prospective educational intervention study.

van Onna M, Gorter S, Maiburg B, Waagenaar G, van Tubergen A.

BJGP Open. 2017 Jan 9;1(1):bjgpopen17X100689. doi: 10.3399/bjgpopen17X100689.

29.

Heterogeneity of Cortical Breaks in Hand Joints of Patients with Rheumatoid Arthritis and Healthy Controls Imaged by High-resolution Peripheral Quantitative Computed Tomography.

Scharmga A, Peters M, van Tubergen A, van den Bergh J, Barnabe C, Finzel S, van Rietbergen B, Geusens P.

J Rheumatol. 2016 Oct;43(10):1914-1920.

PMID:
27698106
30.

Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitis.

Essers I, Boonen A, Busch M, van der Heijde D, Keszei AP, Landewé R, Ramiro S, van Tubergen A.

Rheumatology (Oxford). 2016 Nov;55(11):2014-2022. Epub 2016 Aug 12.

PMID:
27520798
31.

Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reduction.

Baraliakos X, Heldmann F, van den Bosch F, Burmester G, Gaston H, van der Horst-Bruinsma IE, Krause A, Schmidt R, Schneider M, Sieper J, Andermann B, van Tubergen A, Witt M, Braun J.

RMD Open. 2016 Jul 19;2(2):e000272. doi: 10.1136/rmdopen-2016-000272. eCollection 2016.

32.

Visual detection of cortical breaks in hand joints: reliability and validity of high-resolution peripheral quantitative CT compared to microCT.

Scharmga A, Peters M, van Tubergen A, van den Bergh J, de Jong J, Loeffen D, van Rietbergen B, Weijers R, Geusens P.

BMC Musculoskelet Disord. 2016 Jul 11;17:271. doi: 10.1186/s12891-016-1148-y.

33.

Do extra-articular manifestations influence outcome in ankylosing spondylitis? 12-year results from OASIS.

Essers I, Ramiro S, Stolwijk C, Blaauw M, Landewé R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):214-21. Epub 2016 Feb 2.

PMID:
26843505
34.

Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-Regression Analysis.

Stolwijk C, van Onna M, Boonen A, van Tubergen A.

Arthritis Care Res (Hoboken). 2016 Sep;68(9):1320-31. doi: 10.1002/acr.22831. Epub 2016 Jul 27. Review.

35.

Do patients with ankylosing spondylitis adapt to their disease? Evidence from a 'then-test' in patients treated with TNF inhibitors.

Essers I, van Tubergen A, Heldmann F, Baraliakos X, Braun J, Kiltz U, Boonen A.

RMD Open. 2015 Nov 17;1(1):e000164. doi: 10.1136/rmdopen-2015-000164. eCollection 2015.

36.

Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis.

Ramiro S, Landewé R, van Tubergen A, Boonen A, Stolwijk C, Dougados M, van den Bosch F, van der Heijde D.

RMD Open. 2015 Sep 14;1(1):e000153. doi: 10.1136/rmdopen-2015-000153. eCollection 2015.

37.

Education improves referral of patients suspected of having spondyloarthritis by general practitioners: a study with unannounced standardised patients in daily practice.

van Onna M, Gorter S, Maiburg B, Waagenaar G, van Tubergen A.

RMD Open. 2015 Oct 27;1(1):e000152. doi: 10.1136/rmdopen-2015-000152. eCollection 2015.

39.

Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.

Webers C, Essers I, Ramiro S, Stolwijk C, Landewé R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A.

Rheumatology (Oxford). 2016 Mar;55(3):419-28. doi: 10.1093/rheumatology/kev340. Epub 2015 Sep 18.

PMID:
26385369
40.

Implementation of recommended non-pharmacotherapy in rheumatology practice: need for improvement.

van der Linden S, Boonen A, van Tubergen A, Vosse D, Dekker J, Dijkmans B, van der Horst-Bruinsma I, Kapinga T, van der Leeden M, van den Ende C, Hazes JM, Linssen A, Vliet Vlieland T.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1 Suppl 95):S15-7. Epub 2015 Aug 27. No abstract available.

41.

Correction. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study.

Ramiro S, Stolwijk C, van Tubergen A.

Ann Rheum Dis. 2015 Jul;74(7):1482. doi: 10.1136/annrheumdis-2013-204055corr1. No abstract available.

PMID:
26063810
42.

Clinical Tools to Assess and Monitor Spondyloarthritis.

Landewé R, van Tubergen A.

Curr Rheumatol Rep. 2015 Jul;17(7):47. doi: 10.1007/s11926-015-0522-3. Review.

43.

Are patient-reported outcome instruments for ankylosing spondylitis fit for purpose for the axial spondyloarthritis patient? A qualitative and psychometric analysis.

van Tubergen A, Black PM, Coteur G.

Rheumatology (Oxford). 2015 Oct;54(10):1842-51. doi: 10.1093/rheumatology/kev125. Epub 2015 May 21. Review.

PMID:
26001635
44.

Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis.

Poddubnyy D, van Tubergen A, Landewé R, Sieper J, van der Heijde D; Assessment of SpondyloArthritis international Society (ASAS).

Ann Rheum Dis. 2015 Aug;74(8):1483-7. doi: 10.1136/annrheumdis-2014-207151. Epub 2015 May 19. Review.

45.

Hierarchy of Impairment of Spinal Mobility Measures in Ankylosing Spondylitis: Twelve-Year Data.

Ramiro S, Landewé RB, van der Heijde D, Stolwijk C, Dougados M, van den Bosch F, van Tubergen A.

Arthritis Care Res (Hoboken). 2015 Nov;67(11):1571-7. doi: 10.1002/acr.22614.

46.

Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial Spondyloarthritis.

Sieper J, Kivitz A, van Tubergen A, Deodhar A, Coteur G, Woltering F, Landewé R.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1475-80. doi: 10.1002/acr.22594.

47.

EULAR recommendations for patient education for people with inflammatory arthritis.

Zangi HA, Ndosi M, Adams J, Andersen L, Bode C, Boström C, van Eijk-Hustings Y, Gossec L, Korandová J, Mendes G, Niedermann K, Primdahl J, Stoffer M, Voshaar M, van Tubergen A; European League Against Rheumatism (EULAR).

Ann Rheum Dis. 2015 Jun;74(6):954-62. doi: 10.1136/annrheumdis-2014-206807. Epub 2015 Mar 3. Review.

48.

The changing clinical picture and epidemiology of spondyloarthritis.

van Tubergen A.

Nat Rev Rheumatol. 2015 Feb;11(2):110-8. doi: 10.1038/nrrheum.2014.181. Epub 2014 Nov 11. Review.

PMID:
25385414
49.

Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study.

Essers I, Stolwijk C, Boonen A, De Bruin ML, Bazelier MT, de Vries F, van Tubergen A.

Ann Rheum Dis. 2016 Jan;75(1):203-9. doi: 10.1136/annrheumdis-2014-206147. Epub 2014 Oct 31.

PMID:
25362044
50.

Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa Study.

Sieper J, Kivitz A, van Tubergen A, Deodhar A, Szegvari B, Nurminen T, Landewé R.

Value Health. 2014 Nov;17(7):A385-6. doi: 10.1016/j.jval.2014.08.2643. Epub 2014 Oct 26. No abstract available.

Supplemental Content

Loading ...
Support Center